@YogaO One of the questions wasnt about CGM use, but one of the answers (to 3.Q18) was - “R53. Continuous glucose monitoring (CGM) should be considered for patients with T1D and T2D on basal-bolus therapy to improve A1C levels
and reduce hypoglycemia (Grade B; BEL 2). Early reports suggest that even patients not taking insulin may benefit from CGM (Grade D; BEL 4).” (on page 20).
